Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DoseOptics
AddedFeb 16, 2024
UpdatedJun 18, 2026
DoseOptics

DoseOptics

Seed

US-based start-up innovating real-time imaging technology for radiation therapy in cancer treatment.

HQ
Lebanon, NH, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

DoseOptics, founded in Lebanon, United States, is a pioneering startup focused on revolutionizing cancer treatment through innovative imaging technology. The company's core mission is to enhance the precision and effectiveness of radiation therapy by providing real-time imaging solutions. Their flagship product, Beamsite, enables clinicians to visualize and verify radiation therapy in real-time, ensuring that patients receive the most accurate and effective treatment possible. DoseOptics primarily targets the healthcare market, specifically oncology departments in hospitals and cancer treatment centers.

Notable figures associated with DoseOptics include leading experts in medical imaging and radiation therapy. The company has garnered attention from prominent investors in the healthcare technology sector, contributing to its rapid growth and development. Key achievements include successful clinical trials and partnerships with major research institutions, underscoring the efficacy and reliability of their technology. Overall, DoseOptics has made a significant impact by improving the quality of cancer care and advancing the capabilities of radiation therapy.

DoseOptics - Similar Companies

Real Time Imaging Technologies logo

Real Time Imaging Technologies

Radiosight logo

Radiosight

radiosight.com

ViewRay logo

ViewRay

Lumedica logo

Lumedica

Diagnostic Photonics logo

Diagnostic Photonics

CardioOptics logo

CardioOptics

Voximetry logo

Voximetry

voximetry.com

Oncospace logo

Oncospace

oncospace.com

Optain logo

Optain

optainhealth.com

Insight Optics logo

Insight Optics

io.care

Opticent Health logo

Opticent Health

opticenthealth.com

Hura Imaging logo

Hura Imaging

DeepSight Technology logo

DeepSight Technology

deepsightinc.com

VisionScope Technologies logo

VisionScope Technologies

ChestAi logo

ChestAi

DoseOptics - Quick Facts

Who are DoseOptics' competitors?

Companies similar to DoseOptics include Real Time Imaging Technologies, Radiosight, ViewRay and Lumedica.

When was DoseOptics founded?

DoseOptics was founded in 2015.

Where is DoseOptics' headquarters located?

DoseOptics' headquarters is located in Lebanon, NH, US.

When was DoseOptics' last funding round?

DoseOptics' most recent funding round was for $2M (USD) in October 2016.

How much has DoseOptics raised to-date?

As of Oct 1, 2016, DoseOptics has raised a total of $3.4M (USD).

How many employees does DoseOptics have?

DoseOptics has 6 employees as of Feb 4, 2024.

DoseOptics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Imaging
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified